Who owns NEWAMSTERDAM PHARMA CO NV?
- Ticker: NAMSW
- CUSIP Number: n62509117
Tip: Access positions for across all investors
Analyze quarterly positions in Newamsterdam Pharma Co Nv with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Newamsterdam Pharma Co Nv stock
Who bought or sold NEWAMSTERDAM PHARMA CO NV this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Frazier Life Sciences Management | 500k | $5.5M | 0% | Mar 2024 |
|
| RA Capital Management | 333k | $3.7M | 0% | Mar 2024 |
|
| Gts Securities | 121k | $1.3M | 100% | Mar 2024 |
|
| Bain Capital Life Sciences Investors | 100k | $1.1M | 0% | Mar 2024 |
|
| Deerfield Management Company | 93k | $1.0M | 0% | Mar 2024 |
|
| Millennium Management | 75k | $828k | 0% | Mar 2024 |
|
| Monashee Investment Management | 31k | $344k | 100% | Mar 2024 |
|
| Hrt Financial | 30k | $334k | 0% | Mar 2024 |
|
| Laurion Capital Management | 17k | $184k | 0% | Mar 2024 |
|
| Atlantic Trust | 1.0k | $11k | 100% | Mar 2024 |
|
Who sold out of Newamsterdam Pharma Co Nv?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Ensign Peak Advisors | Sep 2023 | 150k | $255k |
| ADAR1 Capital Management | Dec 2023 | 83k | $259k |
| EcoR1 Capital | Dec 2023 | 67k | $745k |
| Westchester Capital Management | Dec 2023 | 31k | $98k |
| Walleye Trading Advisors | Dec 2023 | 23k | $71k |
| Clear Street | Sep 2023 | 14k | $26k |
| Walleye Trading | Dec 2023 | 13k | $41k |
| Exos TFP Holdings | Sep 2023 | 12k | $23k |
| Cutler | Dec 2023 | 5.0k | $15k |